ATF6 and amyotrophic lateral sclerosis: ATF6 expression levels did not correlate with disease severity (ALSFR-R score), disease duration (onset since first ALS motor symptom), progression rate [(48-current ALSFRS-R)/disease duration in months] and disease aggressiveness (D50).